Production (Stage)
biote Corp.
BTMD
$3.53
-$0.55-13.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 199.38M | 197.19M | 193.06M | 187.23M | 187.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 199.38M | 197.19M | 193.06M | 187.23M | 187.32M |
| Cost of Revenue | 57.37M | 58.22M | 57.92M | 56.91M | 57.45M |
| Gross Profit | 142.01M | 138.98M | 135.14M | 130.32M | 129.87M |
| SG&A Expenses | 105.06M | 101.29M | 95.36M | 92.31M | 89.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 162.43M | 159.51M | 153.27M | 149.22M | 146.84M |
| Operating Income | 36.95M | 37.68M | 39.79M | 38.02M | 40.49M |
| Income Before Tax | 21.80M | 1.02M | 11.57M | 19.23M | 17.35M |
| Income Tax Expenses | 100.00K | 886.00K | 2.85M | 3.52M | 4.45M |
| Earnings from Continuing Operations | 21.70 | 0.13 | 8.73 | 15.71 | 12.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.75M | 936.00K | -3.63M | -13.79M | -6.94M |
| Net Income | 18.95M | 1.07M | 5.10M | 1.93M | 5.96M |
| EBIT | 36.95M | 37.68M | 39.79M | 38.02M | 40.49M |
| EBITDA | 38.66M | 39.19M | 40.97M | 39.17M | 41.39M |
| EPS Basic | 0.62 | 0.07 | 0.17 | 0.08 | 0.11 |
| Normalized Basic EPS | 0.44 | 0.58 | 0.49 | 0.16 | 0.32 |
| EPS Diluted | 0.52 | 0.03 | 0.05 | -0.04 | -0.01 |
| Normalized Diluted EPS | 0.41 | 0.56 | 0.49 | 0.17 | 0.33 |
| Average Basic Shares Outstanding | 126.88M | 130.02M | 132.72M | 132.01M | 119.64M |
| Average Diluted Shares Outstanding | 139.58M | 137.24M | 163.31M | 162.09M | 149.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 24.14% | 436.77% | 113.05% | 327.74% | 95.37% |